You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Integrin beta 3 antibody [BV4] (ab7167)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Integrin beta 3 antibody [BV4]
See all Integrin beta 3 products (31) ...

Description

Mouse monoclonal [BV4] to Integrin beta 3

Specificity

This monoclonal antibody binds to human beta-3 integrin subunit present on human endothelium cells.

Tested applications

ICC/IF, IHC-P, IHC-Fr, ELISA, WB, IP, Flow Cytmore details

Cross reactivity

Reacts with

Cow, Human

Positive control

human endothelium cells (expression of integrin alpha V beta 3 may need to be upregulated by phorbol esters stimulation).

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

Preservative: 0.01% Thimerosal / Merthiolate
Constituents: 15mg/ml BSA, 0.25M Sodium chloride, 0.01M Sodium phosphate. pH 7.6

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Monoclonal

Clone number

BV4

Isotype

IgG1

  • Western blot - Integrin beta 3 antibody [BV4] (ab7167)Western blot - Integrin beta 3 antibody [BV4] (ab7167) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Integrin beta 3 antibody [BV4] (ab7167)Immunocytochemistry/ Immunofluorescence - Integrin beta 3 antibody [BV4] (ab7167) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab7167 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Integrin alpha-V/beta-3 is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.

Tissue specificity

Isoform beta-3A and isoform beta-3C are widely expressed. Isoform beta-3A is specifically expressed in osteoblast cells; isoform beta-3C is specifically expressed in prostate and testis.

Involvement in disease

Defects in ITGB3 are a cause of Glanzmann thrombasthenia (GT) [MIM:273800]; also known as thrombasthenia of Glanzmann and Naegeli. GT is the most common inherited disease of platelets. It is an autosomal recessive disorder characterized by mucocutaneous bleeding of mild-to-moderate severity and the inability of this integrin to recognize macromolecular or synthetic peptide ligands. GT has been classified clinically into types I and II. In type I, platelets show absence of the glycoprotein IIb/beta-3 complexes at their surface and lack fibrinogen and clot retraction capability. In type II, the platelets express the glycoprotein IIb/beta-3 complex at reduced levels (5-20% controls), have detectable amounts of fibrinogen, and have low or moderate clot retraction capability. The platelets of GT 'variants' have normal or near normal (60-100%) expression of dysfunctional receptors.

Sequence similarities

Belongs to the integrin beta chain family.
Contains 1 VWFA domain.

Post-translational
modifications

Phosphorylated on tyrosine residues in response to thrombin-induced platelet aggregation. Probably involved in outside-in signaling. A peptide (AA 740-762) is capable of binding GRB2 only when both Tyr-773 and Tyr-785 are phosphorylated. Phosphorylation of Thr-779 inhibits SHC binding.

Cellular localization

Membrane.

Target information above from: UniProt accessionP05106 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • BDPLT2 antibody
  • CD 61 antibody
  • CD61 antibody
  • CD61 antigen antibody
  • GP3A antibody
  • GPIIIa antibody
  • GT antibody
  • HPA 1 antibody
  • HPA 4 antibody
  • Integrin beta 3 (platelet glycoprotein IIIa antigen CD61) antibody
  • Integrin beta chain beta 3 antibody
  • Integrin beta-3 antibody
  • ITB3_HUMAN antibody
  • ITG B3 antibody
  • ITGB 3 antibody
  • ITGB3 antibody
  • NAIT antibody
  • Platelet fibrinogen receptor beta subunit antibody
  • Platelet glycoprotein IIIa antibody
  • platelet glycoprotein IIIa precursor antibody
  • Platelet membrane glycoprotein IIIa antibody
  • PTP antibody
see all

Anti-Integrin beta 3 antibody [BV4] images:

  Western blot - Integrin beta 3 antibody [BV4] (ab7167)

Western blot - Integrin beta 3 antibody [BV4] (ab7167)

Anti-Integrin beta 3 antibody [BV4] (ab7167) at 1/200 dilution + HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Secondary
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size : 87 kDa
Observed band size : 100 kDa (why is the actual band size different from the predicted?)

  Immunocytochemistry/ Immunofluorescence - Integrin beta 3 antibody [BV4] (ab7167)

Immunocytochemistry/ Immunofluorescence - Integrin beta 3 antibody [BV4] (ab7167)

ab7167 staining Intergrin beta 3 in human HUVEC cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in paraformaldehyde and then blocked using 3% BSA for 30 minutes. Samples were then incubated with primary antibody at a 1/100 dilution for 16 hours. The secondary antibody used was a goat anti-mouse IgG conjugated to Cy3® used at a 1/200 dilution.

Image courtesy of an anonymous Abreview.

References for Anti-Integrin beta 3 antibody [BV4] (ab7167)

This product has been referenced in:

  • Galvagni Fet al. Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ Res 106:1839-48 (2010). WB, IP; Human.Read more (PubMed: 20431062) »
  • Yu Fet al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29:4194-204 (2010). WB; Human.Read more (PubMed: 20498642) »

See all 7 publications for this product

Publishing research using ab7167? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"